Literature DB >> 26175637

Perioperative management of antithrombotic and antiplatelet therapy.

Arthur W Bracey.   

Abstract

Keywords:  Anticoagulants/administration & dosage/antidote; apixaban; atrial fibrillation; dabigatran etexilate; heparin; novel oral anticoagulant; rivaroxaban; thromboembolism/prevention & control; warfarin

Mesh：

Substances：

Year:  2015        PMID： 26175637      PMCID： PMC4473618          DOI： 10.14503/THIJ-15-5066

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  13 in total

1.  Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study.

Authors:  R Demeyere; S Gillardin; J Arnout; P F W Strengers
Journal:  Vox Sang       Date:  2010-10       Impact factor: 2.144

2.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

3.  The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

Authors:  Lisa K Hicks; Harriet Bering; Kenneth R Carson; Judith Kleinerman; Vishal Kukreti; Alice Ma; Brigitta U Mueller; Sarah H O'Brien; Marcelo Pasquini; Ravindra Sarode; Lawrence Solberg; Adam E Haynes; Mark A Crowther
Journal:  Blood       Date:  2013-12-04       Impact factor: 22.113

4.  International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy.

Authors:  Gene Gulati; Megan Hevelow; Melissa George; Eric Behling; Jamie Siegel
Journal:  Arch Pathol Lab Med       Date:  2011-04       Impact factor: 5.534

5.  Clinical experience with oral versus intravenous vitamin K for warfarin reversal.

Authors:  Robert Meehan; Maria Tavares; Joseph Sweeney
Journal:  Transfusion       Date:  2012-06-28       Impact factor: 3.157

6.  Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.

Authors:  Scott T Avecilla; Chris Ferrell; Wayne L Chandler; Morayma Reyes
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

Review 7.  How I treat anticoagulated patients undergoing an elective procedure or surgery.

Authors:  Alex C Spyropoulos; James D Douketis
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

8.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

9.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 10.  Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.

Authors:  E A Akl; F F van Doormaal; M Barba; G Kamath; S Y Kim; S Kuipers; S Middeldorp; V Yosuico; H O Dickinson; H J Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more
  1 in total

1.  Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy.

Authors:  Christoph Schregel; Hubert John; Marco Randazzo; Isabelle Keller
Journal:  World J Urol       Date:  2017-07-12       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.